Modular Medical, Inc. financial data

Symbol
MODD on Nasdaq
Location
San Diego, CA
Fiscal year end
31 March
Latest financial report
10-Q - Q4 2025 - 17 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 327% % -33%
Debt-to-equity 29% % 31%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 77,703,547 shares 91%
Common Stock, Shares, Outstanding 77,703,000 shares 91%
Entity Public Float $62,273,909 USD 247%
Common Stock, Value, Issued $78,000 USD 90%
Weighted Average Number of Shares Outstanding, Basic 65,930,000 shares 74%
Weighted Average Number of Shares Outstanding, Diluted 65,930,000 shares 74%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $20,069,000 USD 45%
General and Administrative Expense $6,786,000 USD 50%
Operating Income (Loss) $26,855,000 USD -46%
Nonoperating Income (Expense) $102,000 USD 23%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $7,360,000 USD -53%
Income Tax Expense (Benefit) $2,000 USD 0%
Net Income (Loss) Attributable to Parent $7,360,000 USD -53%
Earnings Per Share, Basic -0.49 USD/shares 7.5%
Earnings Per Share, Diluted -0.49 USD/shares 7.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $2,937,000 USD -58%
Assets, Current $3,466,000 USD -53%
Property, Plant and Equipment, Net $6,327,000 USD 60%
Operating Lease, Right-of-Use Asset $466,000 USD -46%
Assets $10,259,000 USD -16%
Accounts Payable, Current $1,008,000 USD 93%
Accrued Liabilities, Current $707,000 USD 57%
Liabilities, Current $2,179,000 USD 58%
Operating Lease, Liability, Noncurrent $40,000 USD -92%
Liabilities $4,378,000 USD 132%
Retained Earnings (Accumulated Deficit) $106,605,000 USD -34%
Stockholders' Equity Attributable to Parent $5,881,000 USD -43%
Liabilities and Equity $10,259,000 USD -16%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $5,372,000 USD -51%
Net Cash Provided by (Used in) Financing Activities $733,000 USD 249%
Net Cash Provided by (Used in) Investing Activities $934,000 USD -11%
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 77,703,000 shares 91%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2,937,000 USD -58%
Deferred Tax Assets, Valuation Allowance $23,037,000 USD 20%
Deferred Tax Assets, Gross $23,733,000 USD 23%
Operating Lease, Liability $504,000 USD -45%
Payments to Acquire Property, Plant, and Equipment $934,000 USD 11%
Lessee, Operating Lease, Liability, to be Paid $525,000 USD -47%
Property, Plant and Equipment, Gross $9,112,000 USD 70%
Operating Lease, Liability, Current $464,000 USD 13%
Lessee, Operating Lease, Liability, to be Paid, Year Two $405,000 USD -14%
Lessee, Operating Lease, Liability, to be Paid, Year One $405,000 USD -14%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $21,000 USD -72%
Lessee, Operating Lease, Liability, to be Paid, Year Three $405,000 USD -14%
Deferred Tax Assets, Operating Loss Carryforwards $14,343,000 USD 32%
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $1,104,000 USD
Operating Lease, Payments $117,000 USD 4.5%
Additional Paid in Capital $112,402,000 USD 25%
Share-based Payment Arrangement, Expense $2,000 USD -60%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%